Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 10.34
+0.06 (0.58%)
At close: Dec 5, 2025
SHE:301301 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Market Capitalization | 23,059 | 26,414 | 18,672 | 19,894 | - | - | Upgrade
|
| Market Cap Growth | -33.42% | 41.47% | -6.14% | - | - | - | Upgrade
|
| Enterprise Value | 23,564 | 27,694 | 19,880 | 23,322 | - | - | Upgrade
|
| Last Close Price | 10.34 | 11.61 | 8.10 | 8.55 | - | - | Upgrade
|
| PE Ratio | 24.75 | 18.86 | 19.85 | 48.34 | - | - | Upgrade
|
| Forward PE | 26.18 | 16.86 | 20.74 | - | - | - | Upgrade
|
| PS Ratio | 4.87 | 4.59 | 3.87 | 5.21 | - | - | Upgrade
|
| PB Ratio | 2.90 | 3.34 | 2.68 | 3.20 | - | - | Upgrade
|
| P/TBV Ratio | 3.00 | 3.45 | 2.79 | 3.36 | - | - | Upgrade
|
| P/FCF Ratio | 15.80 | 15.11 | 19.71 | 30.87 | - | - | Upgrade
|
| P/OCF Ratio | 15.51 | 14.75 | 14.45 | 28.76 | - | - | Upgrade
|
| EV/Sales Ratio | 4.97 | 4.81 | 4.12 | 6.10 | - | - | Upgrade
|
| EV/EBITDA Ratio | 13.39 | 12.16 | 11.49 | 19.17 | - | - | Upgrade
|
| EV/EBIT Ratio | 19.59 | 15.95 | 16.76 | 34.77 | - | - | Upgrade
|
| EV/FCF Ratio | 16.15 | 15.84 | 20.99 | 36.19 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.18 | 0.28 | 0.53 | 0.77 | 0.91 | Upgrade
|
| Debt / EBITDA Ratio | 0.70 | 0.62 | 1.12 | 2.68 | 3.99 | 4.50 | Upgrade
|
| Debt / FCF Ratio | 0.84 | 0.82 | 2.05 | 5.07 | 4.89 | 7.61 | Upgrade
|
| Asset Turnover | 0.45 | 0.56 | 0.47 | 0.39 | 0.33 | 0.37 | Upgrade
|
| Inventory Turnover | 3.18 | 2.44 | 2.19 | 2.04 | 1.82 | 2.10 | Upgrade
|
| Quick Ratio | 1.27 | 1.37 | 0.85 | 1.13 | 0.66 | 0.72 | Upgrade
|
| Current Ratio | 2.23 | 2.13 | 1.56 | 1.67 | 1.25 | 1.38 | Upgrade
|
| Return on Equity (ROE) | 12.04% | 18.81% | 14.27% | 7.49% | 2.36% | 5.04% | Upgrade
|
| Return on Assets (ROA) | 7.20% | 10.49% | 7.22% | 4.22% | 2.56% | 2.89% | Upgrade
|
| Return on Capital (ROIC) | 8.06% | 11.89% | 8.06% | 4.68% | 2.85% | 3.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.10% | 20.20% | 15.60% | 8.70% | 5.80% | 6.10% | Upgrade
|
| Earnings Yield | 4.06% | 5.30% | 5.04% | 2.07% | - | - | Upgrade
|
| FCF Yield | 6.33% | 6.62% | 5.07% | 3.24% | - | - | Upgrade
|
| Dividend Yield | 2.61% | 2.32% | 2.78% | 1.09% | - | - | Upgrade
|
| Payout Ratio | 67.02% | 38.92% | 30.85% | 34.71% | 150.70% | 25.00% | Upgrade
|
| Buyback Yield / Dilution | 1.11% | 0.75% | -14.28% | -5.59% | 7.21% | - | Upgrade
|
| Total Shareholder Return | 3.73% | 3.07% | -11.50% | -4.51% | 7.21% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.